APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molnupiravir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molnupiravir Market Outlook and Growth Opportunities 2026

30 December 2025199 pages

Choose your research edition.

Industry ResearchMolnupiravir Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Molnupiravir Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Molnupiravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molnupiravir Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Molnupiravir Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Molnupiravir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molnupiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molnupiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molnupiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molnupiravir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molnupiravir market include Merck, Sun Pharma, Optimus Pharma and Beximco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Molnupiravir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molnupiravir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molnupiravir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molnupiravir market size, projected growth trends, production technologies, key applications, and end-use industries.

Molnupiravir Segment by Company

Merck

Sun Pharma

Optimus Pharma

Beximco

Molnupiravir Segment by Type

Patented Drug

Generic Drug

Molnupiravir Segment by Application

Antiviral Drug

COVID-19

Molnupiravir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Molnupiravir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Molnupiravir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molnupiravir significant trends, drivers, influence factors in global and regions.

6. To analyze Molnupiravir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molnupiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molnupiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molnupiravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molnupiravir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molnupiravir industry.

Chapter 3: Detailed analysis of Molnupiravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Molnupiravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Molnupiravir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molnupiravir Industry Trends Table 2. Molnupiravir Industry Drivers Table 3. Molnupiravir Industry Opportunities and Challenges Table 4. Molnupiravir Industry Restraints Table 5. Global Molnupiravir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molnupiravir Revenue Share by Company (2021-2026) Table 7. Global Molnupiravir Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Molnupiravir Sales Volume Share by Company (2021-2026) Table 9. Global Molnupiravir Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Molnupiravir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Molnupiravir Key Company Manufacturing Base & Headquarters Table 12. Global Molnupiravir Company, Product Type & Application Table 13. Global Molnupiravir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Molnupiravir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Patented Drug Table 18. Significant Companies of Generic Drug Table 19. Global Molnupiravir Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Molnupiravir Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Molnupiravir Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Molnupiravir Sales Volume Share by Type (2021-2026) Table 23. Global Molnupiravir Sales Volume Share by Type (2027-2032) Table 24. Global Molnupiravir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Molnupiravir Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Molnupiravir Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Molnupiravir Sales Value Share by Type (2021-2026) Table 28. Global Molnupiravir Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Antiviral Drug Table 30. Significant Companies of COVID-19 Table 31. Global Molnupiravir Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Molnupiravir Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Molnupiravir Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Molnupiravir Sales Volume Share by Application (2021-2026) Table 35. Global Molnupiravir Sales Volume Share by Application (2027-2032) Table 36. Global Molnupiravir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Molnupiravir Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Molnupiravir Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Molnupiravir Sales Value Share by Application (2021-2026) Table 40. Global Molnupiravir Sales Value Share by Application (2027-2032) Table 41. Global Molnupiravir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Molnupiravir Sales by Region (2021-2026) & (K Units) Table 43. Global Molnupiravir Sales Market Share by Region (2021-2026) Table 44. Global Molnupiravir Sales by Region (2027-2032) & (K Units) Table 45. Global Molnupiravir Sales Market Share by Region (2027-2032) Table 46. Global Molnupiravir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Molnupiravir Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Molnupiravir Sales Value Share by Region (2021-2026) Table 49. Global Molnupiravir Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Molnupiravir Sales Value Share by Region (2027-2032) Table 51. Global Molnupiravir Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Molnupiravir Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Molnupiravir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Molnupiravir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Molnupiravir Sales by Country (2021-2026) & (K Units) Table 56. Global Molnupiravir Sales Market Share by Country (2021-2026) Table 57. Global Molnupiravir Sales by Country (2027-2032) & (K Units) Table 58. Global Molnupiravir Sales Market Share by Country (2027-2032) Table 59. Global Molnupiravir Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Molnupiravir Sales Value Market Share by Country (2021-2026) Table 61. Global Molnupiravir Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Molnupiravir Sales Value Market Share by Country (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Molnupiravir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck Molnupiravir Product Portfolio Table 67. Merck Recent Development Table 68. Sun Pharma Company Information Table 69. Sun Pharma Business Overview Table 70. Sun Pharma Molnupiravir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sun Pharma Molnupiravir Product Portfolio Table 72. Sun Pharma Recent Development Table 73. Optimus Pharma Company Information Table 74. Optimus Pharma Business Overview Table 75. Optimus Pharma Molnupiravir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Optimus Pharma Molnupiravir Product Portfolio Table 77. Optimus Pharma Recent Development Table 78. Beximco Company Information Table 79. Beximco Business Overview Table 80. Beximco Molnupiravir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Beximco Molnupiravir Product Portfolio Table 82. Beximco Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Molnupiravir Distributors List Table 86. Molnupiravir Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Molnupiravir Product Image Figure 2. Global Molnupiravir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Molnupiravir Sales (2021-2032) & (K Units) Figure 5. Global Molnupiravir Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Molnupiravir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Patented Drug Image Figure 10. Generic Drug Image Figure 11. Global Molnupiravir Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Molnupiravir Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Molnupiravir Sales Volume Share by Type (2021-2032) Figure 14. Global Molnupiravir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Molnupiravir Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Molnupiravir Sales Value Share by Type (2021-2032) Figure 17. Antiviral Drug Image Figure 18. COVID-19 Image Figure 19. Global Molnupiravir Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Molnupiravir Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Molnupiravir Sales Volume Share by Application (2021-2032) Figure 22. Global Molnupiravir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Molnupiravir Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Molnupiravir Sales Value Share by Application (2021-2032) Figure 25. Global Molnupiravir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Molnupiravir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Molnupiravir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Molnupiravir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 30. North America Molnupiravir Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Molnupiravir Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Molnupiravir Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 36. South America Molnupiravir Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Molnupiravir Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Molnupiravir Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Molnupiravir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Molnupiravir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Molnupiravir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Molnupiravir Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Molnupiravir Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Patented Drug
  • Generic Drug
Applications
  • Antiviral Drug
  • COVID-19
Companies covered
  • Merck
  • Sun Pharma
  • Optimus Pharma
  • Beximco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Molnupiravir Sales Value (2021-2032)
  4. 1.2.2 Global Molnupiravir Sales Volume (2021-2032)
  5. 1.2.3 Global Molnupiravir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Molnupiravir Market Dynamics
  1. 2.1 Molnupiravir Industry Trends
  2. 2.2 Molnupiravir Industry Drivers
  3. 2.3 Molnupiravir Industry Opportunities and Challenges
  4. 2.4 Molnupiravir Industry Restraints
3 Molnupiravir Market by Company
  1. 3.1 Global Molnupiravir Company Revenue Ranking in 2025
  2. 3.2 Global Molnupiravir Revenue by Company (2021-2026)
  3. 3.3 Global Molnupiravir Sales Volume by Company (2021-2026)
  4. 3.4 Global Molnupiravir Average Price by Company (2021-2026)
  5. 3.5 Global Molnupiravir Company Ranking (2024-2026)
  6. 3.6 Global Molnupiravir Company Manufacturing Base and Headquarters
  7. 3.7 Global Molnupiravir Company Product Type and Application
  8. 3.8 Global Molnupiravir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Molnupiravir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Molnupiravir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Molnupiravir Market by Type
  1. 4.1 Molnupiravir Type Introduction
  2. 4.1.1 Patented Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Molnupiravir Sales Volume by Type
  5. 4.2.1 Global Molnupiravir Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Molnupiravir Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Molnupiravir Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Molnupiravir Sales Value by Type
  9. 4.3.1 Global Molnupiravir Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Molnupiravir Sales Value by Type (2021-2032)
  11. 4.3.3 Global Molnupiravir Sales Value Share by Type (2021-2032)
5 Molnupiravir Market by Application
  1. 5.1 Molnupiravir Application Introduction
  2. 5.1.1 Antiviral Drug
  3. 5.1.2 COVID-19
  4. 5.2 Global Molnupiravir Sales Volume by Application
  5. 5.2.1 Global Molnupiravir Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Molnupiravir Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Molnupiravir Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Molnupiravir Sales Value by Application
  9. 5.3.1 Global Molnupiravir Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Molnupiravir Sales Value by Application (2021-2032)
  11. 5.3.3 Global Molnupiravir Sales Value Share by Application (2021-2032)
6 Molnupiravir Regional Sales and Value Analysis
  1. 6.1 Global Molnupiravir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molnupiravir Sales by Region (2021-2032)
  3. 6.2.1 Global Molnupiravir Sales by Region: 2021-2026
  4. 6.2.2 Global Molnupiravir Sales by Region (2027-2032)
  5. 6.3 Global Molnupiravir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Molnupiravir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Molnupiravir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Molnupiravir Sales Value by Region (2027-2032)
  9. 6.5 Global Molnupiravir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Molnupiravir Sales Value (2021-2032)
  12. 6.6.2 North America Molnupiravir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Molnupiravir Sales Value (2021-2032)
  15. 6.7.2 Europe Molnupiravir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Molnupiravir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Molnupiravir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Molnupiravir Sales Value (2021-2032)
  21. 6.9.2 South America Molnupiravir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Molnupiravir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Molnupiravir Sales Value Share by Country, 2025 VS 2032
7 Molnupiravir Country-level Sales and Value Analysis
  1. 7.1 Global Molnupiravir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molnupiravir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Molnupiravir Sales by Country (2021-2032)
  4. 7.3.1 Global Molnupiravir Sales by Country (2021-2026)
  5. 7.3.2 Global Molnupiravir Sales by Country (2027-2032)
  6. 7.4 Global Molnupiravir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Molnupiravir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Molnupiravir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Molnupiravir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Molnupiravir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Molnupiravir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Molnupiravir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Molnupiravir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Molnupiravir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Molnupiravir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Molnupiravir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Molnupiravir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Molnupiravir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Molnupiravir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Molnupiravir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Molnupiravir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Molnupiravir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Molnupiravir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Molnupiravir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Molnupiravir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Molnupiravir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Molnupiravir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Molnupiravir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Molnupiravir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Molnupiravir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Molnupiravir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Molnupiravir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Molnupiravir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Molnupiravir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Molnupiravir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Molnupiravir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Molnupiravir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Molnupiravir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Molnupiravir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Molnupiravir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Molnupiravir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Molnupiravir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Molnupiravir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Molnupiravir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Molnupiravir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Molnupiravir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Molnupiravir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Molnupiravir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Molnupiravir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Molnupiravir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Molnupiravir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Molnupiravir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Molnupiravir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Molnupiravir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Molnupiravir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Molnupiravir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Molnupiravir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Molnupiravir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Molnupiravir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Molnupiravir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Molnupiravir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Molnupiravir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Molnupiravir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Molnupiravir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Molnupiravir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Molnupiravir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Molnupiravir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Molnupiravir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Molnupiravir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Molnupiravir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Molnupiravir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Molnupiravir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Molnupiravir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Molnupiravir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Molnupiravir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Molnupiravir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Molnupiravir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Molnupiravir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Molnupiravir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Molnupiravir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Molnupiravir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Molnupiravir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Molnupiravir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Molnupiravir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Molnupiravir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Molnupiravir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Molnupiravir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Molnupiravir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Molnupiravir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Molnupiravir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Molnupiravir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Molnupiravir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Molnupiravir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Molnupiravir Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Molnupiravir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Molnupiravir Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 Optimus Pharma
  14. 8.3.1 Optimus Pharma Company Information
  15. 8.3.2 Optimus Pharma Business Overview
  16. 8.3.3 Optimus Pharma Molnupiravir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Optimus Pharma Molnupiravir Product Portfolio
  18. 8.3.5 Optimus Pharma Recent Developments
  19. 8.4 Beximco
  20. 8.4.1 Beximco Company Information
  21. 8.4.2 Beximco Business Overview
  22. 8.4.3 Beximco Molnupiravir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beximco Molnupiravir Product Portfolio
  24. 8.4.5 Beximco Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molnupiravir Value Chain Analysis
  2. 9.1.1 Molnupiravir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molnupiravir Sales Mode & Process
  6. 9.2 Molnupiravir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molnupiravir Distributors
  9. 9.2.3 Molnupiravir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst